GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (XMAD:PHM) » Definitions » Net Margin %

Pharma Mar (XMAD:PHM) Net Margin % : 6.06% (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Pharma Mar Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Pharma Mar's Net Income for the three months ended in Mar. 2024 was €2.3 Mil. Pharma Mar's Revenue for the three months ended in Mar. 2024 was €38.0 Mil. Therefore, Pharma Mar's net margin for the quarter that ended in Mar. 2024 was 6.06%.

The historical rank and industry rank for Pharma Mar's Net Margin % or its related term are showing as below:

XMAD:PHM' s Net Margin % Range Over the Past 10 Years
Min: -16.84   Med: 2.07   Max: 50.85
Current: 1.25


XMAD:PHM's Net Margin % is ranked better than
76.46% of 1028 companies
in the Biotechnology industry
Industry Median: -154.79 vs XMAD:PHM: 1.25

Pharma Mar Net Margin % Historical Data

The historical data trend for Pharma Mar's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Net Margin % Chart

Pharma Mar Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.26 50.85 40.40 25.14 0.72

Pharma Mar Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.15 10.87 4.06 -16.83 6.06

Competitive Comparison of Pharma Mar's Net Margin %

For the Biotechnology subindustry, Pharma Mar's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharma Mar's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Mar's Net Margin % distribution charts can be found below:

* The bar in red indicates where Pharma Mar's Net Margin % falls into.



Pharma Mar Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Pharma Mar's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1.137/158.153
=0.72 %

Pharma Mar's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2.3/37.966
=6.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharma Mar  (XMAD:PHM) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Pharma Mar Net Margin % Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharma Mar (XMAD:PHM) Business Description

Traded in Other Exchanges
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and market insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology, Diagnostics, Consumer chemicals, and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar (XMAD:PHM) Headlines

From GuruFocus

Q3 2020 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q1 2022 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q3 2023 Pultegroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

PulteGroup Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024

Q1 2019 PulteGroup Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024